 | • レポートコード：QYR2104Z1705 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、サイトメガロウイルス（CMV）感染のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（シドフォビル、ホスカルネット、バルガンシクロビル、ガンシクロビル）、用途別市場規模（病院、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・サイトメガロウイルス（CMV）感染の市場動向 ・企業の競争状況、市場シェア ・サイトメガロウイルス（CMV）感染の種類別市場規模（シドフォビル、ホスカルネット、バルガンシクロビル、ガンシクロビル） ・サイトメガロウイルス（CMV）感染の用途別市場規模（病院、小売薬局、オンライン薬局） ・サイトメガロウイルス（CMV）感染の北米市場規模2016-2027（アメリカ、カナダ） ・サイトメガロウイルス（CMV）感染のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・サイトメガロウイルス（CMV）感染のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・サイトメガロウイルス（CMV）感染の中南米市場規模2016-2027（メキシコ、ブラジル） ・サイトメガロウイルス（CMV）感染の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、GlaxoSmithKline、Vical、AiCuris Anti-Infective Cures、ViroPharma、Chimerix） ・結論 |
Cytomegalovirus (CMV) infection is one of the common herpesvirus infection with different symptoms, which occurs in people of all ages across the globe. This viral infection is communicable and can easily spread through body fluids such as blood, urine, saliva, semen and breast milk. The infection can spread easily through saliva or urine and the people infected with the CMV may have the virus in their saliva or urine for months. The disease can be transmitted from pregnant women to the baby during the delivery. Blood transfusion and infected organ transplant is yet another mode of disease transmission.
The key factor responsible for growth of cytomegalovirus infection is increasing public awareness related to herpes virus infections which is fueling the diagnosis rate in North America and Europe. North America was observed as the largest market for cytomegalovirus infection treatment followed by Europe. Asia Pacific was anticipated to grow at a fastest CAGR during the forecast period. The key factors assisting the growth of Asia Pacific cytomegalovirus infection treatment market are the rising awareness associated with the rare diseases, developing healthcare infrastructure, high disposable income and government support for novel treatment against rare genetic diseases.
Market Analysis and Insights: Global Cytomegalovirus Infection Market
The global Cytomegalovirus Infection market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cytomegalovirus Infection market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cytomegalovirus Infection market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cytomegalovirus Infection market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cytomegalovirus Infection market.
Global Cytomegalovirus Infection Scope and Market Size
Cytomegalovirus Infection market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cytomegalovirus Infection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Cidofovir
Foscarnet
Valganciclovir
Ganciclovir
Segment by Application
Hospitals
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche
GlaxoSmithKline
Vical
AiCuris Anti-Infective Cures
ViroPharma
Chimerix
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cytomegalovirus Infection Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cidofovir
1.2.3 Foscarnet
1.2.4 Valganciclovir
1.2.5 Ganciclovir
1.3 Market by Application
1.3.1 Global Cytomegalovirus Infection Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cytomegalovirus Infection Market Perspective (2016-2027)
2.2 Cytomegalovirus Infection Growth Trends by Regions
2.2.1 Cytomegalovirus Infection Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cytomegalovirus Infection Historic Market Share by Regions (2016-2021)
2.2.3 Cytomegalovirus Infection Forecasted Market Size by Regions (2022-2027)
2.3 Cytomegalovirus Infection Industry Dynamic
2.3.1 Cytomegalovirus Infection Market Trends
2.3.2 Cytomegalovirus Infection Market Drivers
2.3.3 Cytomegalovirus Infection Market Challenges
2.3.4 Cytomegalovirus Infection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cytomegalovirus Infection Players by Revenue
3.1.1 Global Top Cytomegalovirus Infection Players by Revenue (2016-2021)
3.1.2 Global Cytomegalovirus Infection Revenue Market Share by Players (2016-2021)
3.2 Global Cytomegalovirus Infection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cytomegalovirus Infection Revenue
3.4 Global Cytomegalovirus Infection Market Concentration Ratio
3.4.1 Global Cytomegalovirus Infection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cytomegalovirus Infection Revenue in 2020
3.5 Cytomegalovirus Infection Key Players Head office and Area Served
3.6 Key Players Cytomegalovirus Infection Product Solution and Service
3.7 Date of Enter into Cytomegalovirus Infection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cytomegalovirus Infection Breakdown Data by Type
4.1 Global Cytomegalovirus Infection Historic Market Size by Type (2016-2021)
4.2 Global Cytomegalovirus Infection Forecasted Market Size by Type (2022-2027)
5 Cytomegalovirus Infection Breakdown Data by Application
5.1 Global Cytomegalovirus Infection Historic Market Size by Application (2016-2021)
5.2 Global Cytomegalovirus Infection Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cytomegalovirus Infection Market Size (2016-2027)
6.2 North America Cytomegalovirus Infection Market Size by Type
6.2.1 North America Cytomegalovirus Infection Market Size by Type (2016-2021)
6.2.2 North America Cytomegalovirus Infection Market Size by Type (2022-2027)
6.2.3 North America Cytomegalovirus Infection Market Size by Type (2016-2027)
6.3 North America Cytomegalovirus Infection Market Size by Application
6.3.1 North America Cytomegalovirus Infection Market Size by Application (2016-2021)
6.3.2 North America Cytomegalovirus Infection Market Size by Application (2022-2027)
6.3.3 North America Cytomegalovirus Infection Market Size by Application (2016-2027)
6.4 North America Cytomegalovirus Infection Market Size by Country
6.4.1 North America Cytomegalovirus Infection Market Size by Country (2016-2021)
6.4.2 North America Cytomegalovirus Infection Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cytomegalovirus Infection Market Size (2016-2027)
7.2 Europe Cytomegalovirus Infection Market Size by Type
7.2.1 Europe Cytomegalovirus Infection Market Size by Type (2016-2021)
7.2.2 Europe Cytomegalovirus Infection Market Size by Type (2022-2027)
7.2.3 Europe Cytomegalovirus Infection Market Size by Type (2016-2027)
7.3 Europe Cytomegalovirus Infection Market Size by Application
7.3.1 Europe Cytomegalovirus Infection Market Size by Application (2016-2021)
7.3.2 Europe Cytomegalovirus Infection Market Size by Application (2022-2027)
7.3.3 Europe Cytomegalovirus Infection Market Size by Application (2016-2027)
7.4 Europe Cytomegalovirus Infection Market Size by Country
7.4.1 Europe Cytomegalovirus Infection Market Size by Country (2016-2021)
7.4.2 Europe Cytomegalovirus Infection Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cytomegalovirus Infection Market Size (2016-2027)
8.2 Asia-Pacific Cytomegalovirus Infection Market Size by Type
8.2.1 Asia-Pacific Cytomegalovirus Infection Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cytomegalovirus Infection Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cytomegalovirus Infection Market Size by Type (2016-2027)
8.3 Asia-Pacific Cytomegalovirus Infection Market Size by Application
8.3.1 Asia-Pacific Cytomegalovirus Infection Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cytomegalovirus Infection Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cytomegalovirus Infection Market Size by Application (2016-2027)
8.4 Asia-Pacific Cytomegalovirus Infection Market Size by Region
8.4.1 Asia-Pacific Cytomegalovirus Infection Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cytomegalovirus Infection Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cytomegalovirus Infection Market Size (2016-2027)
9.2 Latin America Cytomegalovirus Infection Market Size by Type
9.2.1 Latin America Cytomegalovirus Infection Market Size by Type (2016-2021)
9.2.2 Latin America Cytomegalovirus Infection Market Size by Type (2022-2027)
9.2.3 Latin America Cytomegalovirus Infection Market Size by Type (2016-2027)
9.3 Latin America Cytomegalovirus Infection Market Size by Application
9.3.1 Latin America Cytomegalovirus Infection Market Size by Application (2016-2021)
9.3.2 Latin America Cytomegalovirus Infection Market Size by Application (2022-2027)
9.3.3 Latin America Cytomegalovirus Infection Market Size by Application (2016-2027)
9.4 Latin America Cytomegalovirus Infection Market Size by Country
9.4.1 Latin America Cytomegalovirus Infection Market Size by Country (2016-2021)
9.4.2 Latin America Cytomegalovirus Infection Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cytomegalovirus Infection Market Size (2016-2027)
10.2 Middle East & Africa Cytomegalovirus Infection Market Size by Type
10.2.1 Middle East & Africa Cytomegalovirus Infection Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cytomegalovirus Infection Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cytomegalovirus Infection Market Size by Type (2016-2027)
10.3 Middle East & Africa Cytomegalovirus Infection Market Size by Application
10.3.1 Middle East & Africa Cytomegalovirus Infection Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cytomegalovirus Infection Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cytomegalovirus Infection Market Size by Application (2016-2027)
10.4 Middle East & Africa Cytomegalovirus Infection Market Size by Country
10.4.1 Middle East & Africa Cytomegalovirus Infection Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cytomegalovirus Infection Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Cytomegalovirus Infection Introduction
11.1.4 Roche Revenue in Cytomegalovirus Infection Business (2016-2021)
11.1.5 Roche Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Cytomegalovirus Infection Introduction
11.2.4 GlaxoSmithKline Revenue in Cytomegalovirus Infection Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 Vical
11.3.1 Vical Company Details
11.3.2 Vical Business Overview
11.3.3 Vical Cytomegalovirus Infection Introduction
11.3.4 Vical Revenue in Cytomegalovirus Infection Business (2016-2021)
11.3.5 Vical Recent Development
11.4 AiCuris Anti-Infective Cures
11.4.1 AiCuris Anti-Infective Cures Company Details
11.4.2 AiCuris Anti-Infective Cures Business Overview
11.4.3 AiCuris Anti-Infective Cures Cytomegalovirus Infection Introduction
11.4.4 AiCuris Anti-Infective Cures Revenue in Cytomegalovirus Infection Business (2016-2021)
11.4.5 AiCuris Anti-Infective Cures Recent Development
11.5 ViroPharma
11.5.1 ViroPharma Company Details
11.5.2 ViroPharma Business Overview
11.5.3 ViroPharma Cytomegalovirus Infection Introduction
11.5.4 ViroPharma Revenue in Cytomegalovirus Infection Business (2016-2021)
11.5.5 ViroPharma Recent Development
11.6 Chimerix
11.6.1 Chimerix Company Details
11.6.2 Chimerix Business Overview
11.6.3 Chimerix Cytomegalovirus Infection Introduction
11.6.4 Chimerix Revenue in Cytomegalovirus Infection Business (2016-2021)
11.6.5 Chimerix Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cytomegalovirus Infection Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cidofovir
Table 3. Key Players of Foscarnet
Table 4. Key Players of Valganciclovir
Table 5. Key Players of Ganciclovir
Table 6. Global Cytomegalovirus Infection Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cytomegalovirus Infection Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cytomegalovirus Infection Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Cytomegalovirus Infection Market Share by Regions (2016-2021)
Table 10. Global Cytomegalovirus Infection Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Cytomegalovirus Infection Market Share by Regions (2022-2027)
Table 12. Cytomegalovirus Infection Market Trends
Table 13. Cytomegalovirus Infection Market Drivers
Table 14. Cytomegalovirus Infection Market Challenges
Table 15. Cytomegalovirus Infection Market Restraints
Table 16. Global Cytomegalovirus Infection Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Cytomegalovirus Infection Market Share by Players (2016-2021)
Table 18. Global Top Cytomegalovirus Infection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cytomegalovirus Infection as of 2020)
Table 19. Ranking of Global Top Cytomegalovirus Infection Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Cytomegalovirus Infection Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cytomegalovirus Infection Product Solution and Service
Table 23. Date of Enter into Cytomegalovirus Infection Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cytomegalovirus Infection Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Cytomegalovirus Infection Revenue Market Share by Type (2016-2021)
Table 27. Global Cytomegalovirus Infection Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Cytomegalovirus Infection Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Cytomegalovirus Infection Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Cytomegalovirus Infection Revenue Market Share by Application (2016-2021)
Table 31. Global Cytomegalovirus Infection Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Cytomegalovirus Infection Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Cytomegalovirus Infection Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Cytomegalovirus Infection Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Cytomegalovirus Infection Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Cytomegalovirus Infection Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Cytomegalovirus Infection Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Cytomegalovirus Infection Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Cytomegalovirus Infection Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Cytomegalovirus Infection Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Cytomegalovirus Infection Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Cytomegalovirus Infection Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Cytomegalovirus Infection Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Cytomegalovirus Infection Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cytomegalovirus Infection Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cytomegalovirus Infection Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cytomegalovirus Infection Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Cytomegalovirus Infection Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cytomegalovirus Infection Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Cytomegalovirus Infection Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Cytomegalovirus Infection Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Cytomegalovirus Infection Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Cytomegalovirus Infection Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Cytomegalovirus Infection Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Cytomegalovirus Infection Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Cytomegalovirus Infection Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cytomegalovirus Infection Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cytomegalovirus Infection Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cytomegalovirus Infection Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Cytomegalovirus Infection Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cytomegalovirus Infection Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Cytomegalovirus Infection Market Size by Country (2022-2027) & (US$ Million)
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Cytomegalovirus Infection Product
Table 66. Roche Revenue in Cytomegalovirus Infection Business (2016-2021) & (US$ Million)
Table 67. Roche Recent Development
Table 68. GlaxoSmithKline Company Details
Table 69. GlaxoSmithKline Business Overview
Table 70. GlaxoSmithKline Cytomegalovirus Infection Product
Table 71. GlaxoSmithKline Revenue in Cytomegalovirus Infection Business (2016-2021) & (US$ Million)
Table 72. GlaxoSmithKline Recent Development
Table 73. Vical Company Details
Table 74. Vical Business Overview
Table 75. Vical Cytomegalovirus Infection Product
Table 76. Vical Revenue in Cytomegalovirus Infection Business (2016-2021) & (US$ Million)
Table 77. Vical Recent Development
Table 78. AiCuris Anti-Infective Cures Company Details
Table 79. AiCuris Anti-Infective Cures Business Overview
Table 80. AiCuris Anti-Infective Cures Cytomegalovirus Infection Product
Table 81. AiCuris Anti-Infective Cures Revenue in Cytomegalovirus Infection Business (2016-2021) & (US$ Million)
Table 82. AiCuris Anti-Infective Cures Recent Development
Table 83. ViroPharma Company Details
Table 84. ViroPharma Business Overview
Table 85. ViroPharma Cytomegalovirus Infection Product
Table 86. ViroPharma Revenue in Cytomegalovirus Infection Business (2016-2021) & (US$ Million)
Table 87. ViroPharma Recent Development
Table 88. Chimerix Company Details
Table 89. Chimerix Business Overview
Table 90. Chimerix Cytomegalovirus Infection Product
Table 91. Chimerix Revenue in Cytomegalovirus Infection Business (2016-2021) & (US$ Million)
Table 92. Chimerix Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cytomegalovirus Infection Market Share by Type: 2020 VS 2027
Figure 2. Cidofovir Features
Figure 3. Foscarnet Features
Figure 4. Valganciclovir Features
Figure 5. Ganciclovir Features
Figure 6. Global Cytomegalovirus Infection Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Cytomegalovirus Infection Report Years Considered
Figure 11. Global Cytomegalovirus Infection Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Cytomegalovirus Infection Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Cytomegalovirus Infection Market Share by Regions: 2020 VS 2027
Figure 14. Global Cytomegalovirus Infection Market Share by Regions (2022-2027)
Figure 15. Global Cytomegalovirus Infection Market Share by Players in 2020
Figure 16. Global Top Cytomegalovirus Infection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cytomegalovirus Infection as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Cytomegalovirus Infection Revenue in 2020
Figure 18. Global Cytomegalovirus Infection Revenue Market Share by Type (2016-2021)
Figure 19. Global Cytomegalovirus Infection Revenue Market Share by Type (2022-2027)
Figure 20. North America Cytomegalovirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Cytomegalovirus Infection Market Share by Type (2016-2027)
Figure 22. North America Cytomegalovirus Infection Market Share by Application (2016-2027)
Figure 23. North America Cytomegalovirus Infection Market Share by Country (2016-2027)
Figure 24. United States Cytomegalovirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Cytomegalovirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cytomegalovirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cytomegalovirus Infection Market Share by Type (2016-2027)
Figure 28. Europe Cytomegalovirus Infection Market Share by Application (2016-2027)
Figure 29. Europe Cytomegalovirus Infection Market Share by Country (2016-2027)
Figure 30. Germany Cytomegalovirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Cytomegalovirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Cytomegalovirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Cytomegalovirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Cytomegalovirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Cytomegalovirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cytomegalovirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cytomegalovirus Infection Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Cytomegalovirus Infection Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Cytomegalovirus Infection Market Share by Region (2016-2027)
Figure 40. China Cytomegalovirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Cytomegalovirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Cytomegalovirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Cytomegalovirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Cytomegalovirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Cytomegalovirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cytomegalovirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cytomegalovirus Infection Market Share by Type (2016-2027)
Figure 48. Latin America Cytomegalovirus Infection Market Share by Application (2016-2027)
Figure 49. Latin America Cytomegalovirus Infection Market Share by Country (2016-2027)
Figure 50. Mexico Cytomegalovirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Cytomegalovirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cytomegalovirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cytomegalovirus Infection Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Cytomegalovirus Infection Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Cytomegalovirus Infection Market Share by Country (2016-2027)
Figure 56. Turkey Cytomegalovirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Cytomegalovirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Cytomegalovirus Infection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Roche Revenue Growth Rate in Cytomegalovirus Infection Business (2016-2021)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Cytomegalovirus Infection Business (2016-2021)
Figure 61. Vical Revenue Growth Rate in Cytomegalovirus Infection Business (2016-2021)
Figure 62. AiCuris Anti-Infective Cures Revenue Growth Rate in Cytomegalovirus Infection Business (2016-2021)
Figure 63. ViroPharma Revenue Growth Rate in Cytomegalovirus Infection Business (2016-2021)
Figure 64. Chimerix Revenue Growth Rate in Cytomegalovirus Infection Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
世界のサイトメガロウイルス（CMV）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cytomegalovirus Therapeutics Market The global Cytomegalovirus Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integri…- 世界のサイトメガロウイルス（CMV）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cytomegalovirus Therapeutics Market The global Cytomegalovirus Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integri…
- 世界のサイトメガロウイルス（CMV）網膜炎治療市場規模・現状・予測（2021年-2027年） Ophthalmology is the branch of medical science that deals with the management and study of anatomy, physiology, and diseases related to the human eye. Globally, the incidence of eye disorders and vision loss are becoming major public health issues. Some of the major eye diseases include age-related …
- 世界のヒトパピローマウイルス・サイトメガロウイルス治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Human Papillomavirus and Cytomegalovirus Therapeutics Market The global Human Papillomavirus and Cytomegalovirus Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-s…
- 世界の尿路感染症治療市場規模・現状・予測（2021年-2027年） Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasin…